Lennard Ostendorf, MD, PhD

Postdoctoral Fellow
Charité – University Medicine Berlin
Boston, Massachusetts, United States

Disclosure information not submitted.

Presentation(s):

• Daratumumab Depletes Pathogenic Antibody-Secreting Cells, Reduces Type-I Interferon Activity and Improves T Cell Function in Systemic Lupus Erythematosus

  Wednesday, June 25, 2025
  4:30pm - 4:45pm East Coast USA Time